Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: NEOMATRIX THERAPEUTICS INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-09-09 to 2025-09-08
Current total value of award: $2923902
Description: PER SECTION 711 OF THE 2019 NDAA USAMRAA TRANSFERRED TO DHA 10/1/2022. CNP8 DELIVERED TOPICALLY IN A TYROSINE-DERIVED FIBER MAT TO REDUCE BURN INJURY PROGRESSION-SPEED WOUND CLOSURE-AND MITIGATE SCARRING-IN SUPPORT OF THE CDMRP JWMRP 200170